On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Save 20% on PRs and Gain Exclusive Benefits with NNW Prime! Click to View Details
TuesdayMar 14, 2017 5:00 pm

Novelion Therapeutics, Inc. (NASDAQ: NVLN) Starts Presentation at 29th Annual Roth Conference

Novelion Therapeutics (NASDAQ: NVLN) is a biopharmaceutical company dedicated to developing new standards of care for individuals living with rare diseases. The company seeks to advance its portfolio of rare disease therapies by investing in science and clinical development. Novelion has a diversified commercial portfolio through its indirect subsidiary, Aegerion Pharmaceuticals, Inc., which includes MYALEPT® and JUXTAPID®, and is also developing zuretinol acetate for the potential treatment of inherited retinal disease caused by underlying mutations in RPE65 or LRAT genes. For more information, visit the company’s website at www.novelion.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press…

Continue Reading

TuesdayMar 14, 2017 5:00 pm

ATN International, Inc. (NASDAQ: ATNI) Starts Presentation at 29th Annual ROTH Conference

ATN International (NASDAQ: ATNI), headquartered in Beverly, Massachusetts, provides telecommunications services to rural, niche and other under-served markets and geographies in the United States, Bermuda and the Caribbean and owns and operates solar power systems in select locations in the United States and India. Through its operating subsidiaries, the company provides both wireless and wireline connectivity to residential and business customers, including a range of mobile wireless solutions, local exchange services and broadband internet services as well as distributed solar electric power to corporate, utility and municipal customers. Additionally, ATN is the owner and operator of terrestrial and submarine fiber optic transport systems. For more information, visit the…

Continue Reading

TuesdayMar 14, 2017 4:30 pm

H2O Innovation, Inc. (HEOFF) Starts Presentation at 29th Annual ROTH Conference

H2O Innovation (OTC: HEOFF) designs and provides custom-built, integrated water treatment solutions based on membrane filtration technology for municipal, industrial, energy and natural resources end-users. The company’s activities rely on three pillars which are i) water and wastewater projects; ii) specialty products and services, including a complete line of specialty chemicals, consumables, specialized products for the water treatment industry as well as control and monitoring systems; and iii) operation and maintenance services for water and wastewater treatment systems. For more information, visit the company’s website at www.h2oinnovation.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services…

Continue Reading

TuesdayMar 14, 2017 4:30 pm

MaxLinear, Inc. (NYSE: MXL) Starts Presentation at 29th Annual Roth Conference

MaxLinear (NYSE: MXL) provides radio-frequency (RF) and mixed-signal circuits for broadband communications, data center, metro, and long-haul transport network applications worldwide. The company offers RF receivers and RF receiver systems-on-chips to receive and demodulate broadband signals, modem solutions, and physical medium devices that provide a constant current source, current-to-voltage regulation, and data alignment and retiming functionality in optical interconnect applications. Its products are integrated into a range of electronic devices, including cable and terrestrial and satellite set-top boxes and gates, DOCSIS data and voice gateways, hybrid analog and digital televisions, satellite low-noise blocker transponders or outdoor units, and physical medium…

Continue Reading

TuesdayMar 14, 2017 4:30 pm

Cryoport, Inc. (NASDAQ: CYRX) Starts Presentation at 29th Annual ROTH Conference

Cryoport (NASDAQ: CYRX) is a global provider of cold chain logistics solutions for temperature-sensitive life sciences commodities. The company serves the biopharmaceutical market with logistics solutions for biologic materials, such as regenerative medicine, including immunotherapies, stem cells and CAR-T cells. The company's solutions are used by points-of-care, CRO's, central laboratories, pharmaceutical companies, manufacturers, and university researchers. The company also serves the reproductive medicine market, primarily in IVF and surrogacy; and the animal health market, primarily in the areas of vaccines and reproduction. Cryoport's proprietary Cryoport Express® Shippers, Cryoportal™ Logistics Management Platform, SmartPak II™ Condition Monitoring System and geo-sensing technology, paired…

Continue Reading

TuesdayMar 14, 2017 4:30 pm

Aerie Pharmaceuticals, Inc. (NASDAQ: AERI) Starts Presentation at 29th Annual ROTH Conference

Aerie Pharmaceuticals (NASDAQ: AERI) is a clinical stage pharmaceutical company focusing on the discovery of innovative treatments for glaucoma and other eye ailments. Its leading product candidates, Rhopressa™ and Roclatan™, are believed to be effective for most glaucoma patients, based on clinical trials results, and are currently in different stages of development in view of commercialization. Aerie is also focused on the development of additional product candidates and technologies in ophthalmology. For more information, visit the company’s website at www.aeriepharma.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication…

Continue Reading

TuesdayMar 14, 2017 4:30 pm

Aegion Corp. (NASDAQ: AEGN) Starts Presentation at 29th Annual ROTH Conference

Aegion (NASDAQ: AEGN) maintains, rehabilitates and strengthens infrastructure around the world.  Since 1971, the company has played a pioneering role in finding transformational solutions to rehabilitate aging infrastructure, primarily pipelines in the wastewater, water, energy, mining and refining industries. Aegion also maintains the efficient operation of refineries and other industrial facilities and provides innovative solutions for the strengthening of buildings, bridges and other structures. For more information, visit the company’s website at www.aegion.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution…

Continue Reading

TuesdayMar 14, 2017 4:30 pm

Glu Mobile, Inc. (NASDAQ: GLUU) Starts Presentation at 29th Annual ROTH Conference

Glu Mobile (NASDAQ:GLUU) is a global developer and publisher of free-to-play mobile games. The company is focused on creating compelling original IP games such as Contract Killer, Cooking Dash, Covet Fashion, Deer Hunter, Design Home, Quizup, Racing Rivals, and Tap Sports Baseball, and branded IP games including Gordon Ramsay Dash, Kendall & Kylie, and Kim Kardashian: Hollywood on the App Store, Google Play and Amazon Appstore. Founded in 2001, Glu is headquartered in San Francisco with U.S. offices outside Seattle and in Burlingame, San Mateo, Long Beach and Portland, and international locations in Canada, China, India, Japan, and Russia. For…

Continue Reading

TuesdayMar 14, 2017 4:00 pm

Hortonworks, Inc. (NASDAQ: HDP) Starts Presentation at 29th Annual ROTH Conference

Hortonworks (NASDAQ: HDP) creates, distributes and supports enterprise-ready open data platforms and modern data applications that deliver actionable intelligence from all data: data-in-motion and data-at-rest. The company is focused on driving innovation in open source communities such as Apache Hadoop, Apache NiFi and Apache Spark. Along with its 2,100+ partners, Hortonworks provides the knowledge, training and services that allow customers to unlock transformational value for their organizations across any line of business. For more information, visit the company’s website at www.hortonworks.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social…

Continue Reading

TuesdayMar 14, 2017 4:00 pm

Intec Pharma Ltd. (NASDAQ: NTEC) Starts Presentation at 29th Annual ROTH Conference

Intec Pharma (NASDAQ: NTEC) is a clinical stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology. Accordion Pill is an oral drug delivery system that is designed to improve the efficacy and safety of drugs by utilizing an efficient gastric retention and specific release mechanism. The company's product pipeline currently includes three product candidates in clinical trial stages: Accordion Pill Carbidopa/Levodopa, currently in phase III; Accordion Pill Zaleplon; and an Accordion Pill that is being developed for the prevention and treatment of gastroduodenal and small bowel ulcers induced by Nonsteroidal Anti-Inflammatory Drugs. In addition,…

Continue Reading

Contact us: 212.418.1217